Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
First SpaceX booster for upgraded Starship fails during test in Texas - 2World’s tallest bridge and biggest museum named ‘greatest places of 2026’
- 3Raw oysters linked to ongoing salmonella outbreak infecting 64 across 22 states: CDC
- 4Support Your Wellness: 20-Minute Home Exercises That Work
- 5Which sandwich do you find totally delectable? !
- Key Training: Picking a Significant for Monetary Achievement
- Manual for Financial plan Agreeable PC
- When does Spotify Wrapped come out? The music streamer says 'soon.'
- Benin coup thwarted by loyalist troops, president tells nation
- Ukrainian troops showed 'greater tactical imagination' than Western trainers, British officer says, pointing to their ambush tactics
- From Iran to Israel: An Iranian volunteer’s unlikely stand in wartime
- NI economy losing momentum due to Iran crisis
- Mexico says a third of 130,000 missing people might be alive, fueling criticisms by families
- Can scientists detect life without knowing what it looks like? Research using machine learning offers a new way
